(Total Views: 118)
Posted On: 09/18/2020 3:35:46 PM
Post# of 25672
$SGEN News Article - Seattle Genetics and Astellas Announce PADCEV (enfortumab vedotin-ejfv) Significantly Improved Overall Survival in Phase 3 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer https://marketwirenews.com/news-releases/seat...21096.html
(0)
(0)
My Twitter: WhyteStocks
